식이보충제 위탁생산 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 제형별, 지역별 및 부문별 예측(2026-2033년)

Dietary Supplements Contract Manufacturing Market Summary

The global dietary supplements contract manufacturing market size was valued at USD 22.6 billion in 2025 and is projected to grow from USD 25.4 billion in 2026 to USD 58.9 billion by 2033, at a CAGR of 12.8% from 2026 to 2033. Asia Pacific dominated the market, accounting for a revenue share of 33.8% in 2025. The growth is driven by the increasing demand for dietary supplements, the rising obese population, a growing number of market players and rising consumer demand for personalized and condition-specific supplements.

Dietary Supplements Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global dietary supplements contract manufacturing market report based on product, dosage form, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Proteins and Amino Acid Supplements
• Multivitamin, Multi-Mineral, and Antioxidant Supplements
• Weight Management and Meal Replacer Supplements
• Other Supplements
• Dosage Form Outlook (Revenue, USD Billion, 2021 - 2033)
• Tablets
• Capsules
• Liquid Oral
• Powder In Sachet / Jar
• Gummies
• Others
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Dosage Form
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Top-Down Analysis
  • 1.7.3. Bottom-up Approach
  • 1.7.4. Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Dietary Supplements Contract Manufacturing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Demand for Dietary Supplements
    • 3.2.1.2. Rising Obese Population
    • 3.2.1.3. Growing Number of Market Players
    • 3.2.1.4. Rising Consumer Demand for Personalized and Condition-Specific Supplements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent Regulatory Compliance and Quality Control Requirements
    • 3.2.2.2. Supply Chain Volatility and Fluctuating Raw Material Costs
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. Tariff Impact Analysis
• 3.6. Value Chain Analysis
  • 3.6.1. Supply Trends
  • 3.6.2. Demand Trends
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Force Analysis
  • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Dietary Supplements Contract Manufacturing Market: Product Estimates & Trend Analysis

• 4.1. Dietary Supplements Contract Manufacturing Market, By Product: Segment Dashboard
• 4.2. Dietary Supplements Contract Manufacturing Market, By Product: Movement Analysis
• 4.3. Dietary Supplements Contract Manufacturing Market Estimates & Forecasts, By Service, 2021 - 2033
• 4.4. Proteins and Amino Acid Supplements
  • 4.4.1. Proteins and Amino Acid Supplements Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 4.5. Multivitamin, Multi-Mineral, and Antioxidant Supplements
  • 4.5.1. Multivitamin, Multi-Mineral, and Antioxidant Supplements Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 4.6. Weight Management and Meal Replacer Supplements
  • 4.6.1. Weight Management and Meal Replacer Supplements Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 4.7. Other Supplements
  • 4.7.1. Other Supplements Market Estimates and Forecasts 2021 to 2033 (USD Billion)

Chapter 5. Dietary Supplements Contract Manufacturing Market: Dosage Form Estimates & Trend Analysis

• 5.1. Dietary Supplements Contract Manufacturing Market, By Dosage Form: Segment Dashboard
• 5.2. Dietary Supplements Contract Manufacturing Market, By Dosage Form: Movement Analysis
• 5.3. Dietary Supplements Contract Manufacturing Market Estimates & Forecasts, By Dosage Form, 2021 - 2033
• 5.4. Tablets
  • 5.4.1. Tablets Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.5. Capsules
  • 5.5.1. Capsules Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.6. Liquid Oral
  • 5.6.1. Liquid Oral Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.7. Powder In Sachet / Jar
  • 5.7.1. Powder In Sachet / Jar Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.8. Gummies
  • 5.8.1. Gummies Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.9. Others
  • 5.9.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Billion)

Chapter 6. Dietary Supplements Contract Manufacturing Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Dashboard
• 6.2. Regional Market Share Analysis, 2025 & 2033
• 6.3. North America
  • 6.3.1. North America Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.3.2. U.S
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. U.S. Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.3.3. Canada
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. Canada Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.3.4. Mexico
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Competitive Scenario
    • 6.3.4.3. Regulatory Framework
    • 6.3.4.4. Mexico Market Estimates and Forecasts, 2021-2033 (USD Billion)
• 6.4. Europe
  • 6.4.1. Europe Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.4.2. UK
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. UK Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.4.3. Germany
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Germany Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.4.4. France
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. France Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.4.5. Italy
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Competitive Scenario
    • 6.4.5.3. Regulatory Framework
    • 6.4.5.4. Italy Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.4.6. Spain
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Competitive Scenario
    • 6.4.6.3. Regulatory Framework
    • 6.4.6.4. Spain Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.4.7. Denmark
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Competitive Scenario
    • 6.4.7.3. Regulatory Framework
    • 6.4.7.4. Denmark Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.4.8. Sweden
    • 6.4.8.1. Key Country Dynamics
    • 6.4.8.2. Competitive Scenario
    • 6.4.8.3. Regulatory Framework
    • 6.4.8.4. Sweden Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.4.9. Norway
    • 6.4.9.1. Key Country Dynamics
    • 6.4.9.2. Competitive Scenario
    • 6.4.9.3. Regulatory Framework
    • 6.4.9.4. Norway Market Estimates and Forecasts, 2021-2033 (USD Billion)
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.5.2. Japan
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Japan Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.5.3. China
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. China Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.5.4. India
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. India Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.5.5. Thailand
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Framework
    • 6.5.5.4. Thailand Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.5.6. South Korea
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Framework
    • 6.5.6.4. South Korea Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.5.7. Australia
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Australia Market Estimates and Forecasts, 2021-2033 (USD Billion)
• 6.6. Latin America
  • 6.6.1. Latin America Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.6.2. Brazil
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Brazil Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.6.3. Argentina
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Argentina Market Estimates and Forecasts, 2021-2033 (USD Billion)
• 6.7. MEA
  • 6.7.1. MEA Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.7.2. South Africa
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. South Africa Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.7.3. Saudi Arabia
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021-2033 (USD Billion)
  • 6.7.4. UAE
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. UAE Market Estimates and Forecasts, 2021-2033 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Key Participant Categorization
  • 7.1.1. Market Leaders
  • 7.1.2. Emerging Players
• 7.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 7.3. Company Profiles
  • 7.3.1. Ashland
    • 7.3.1.1. Company Overview
    • 7.3.1.2. Financial Performance
    • 7.3.1.3. Service Benchmarking
    • 7.3.1.4. Strategic Initiatives
  • 7.3.2. Glanbia plc
    • 7.3.2.1. Company Overview
    • 7.3.2.2. Financial Performance
    • 7.3.2.3. Service Benchmarking
    • 7.3.2.4. Strategic Initiatives
  • 7.3.3. Lonza Group Ltd
    • 7.3.3.1. Company Overview
    • 7.3.3.2. Financial Performance
    • 7.3.3.3. Service Benchmarking
    • 7.3.3.4. Strategic Initiatives
  • 7.3.4. CAPTEK Softgel International Inc.
    • 7.3.4.1. Company Overview
    • 7.3.4.2. Financial Performance
    • 7.3.4.3. Service Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. Catalent, Inc
    • 7.3.5.1. Company Overview
    • 7.3.5.2. Financial Performance
    • 7.3.5.3. Service Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. Trividia Manufacturing Solutions, Inc.
    • 7.3.6.1. Company Overview
    • 7.3.6.2. Financial Performance
    • 7.3.6.3. Service Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. Biotrex Nutraceuticals
    • 7.3.7.1. Company Overview
    • 7.3.7.2. Financial Performance
    • 7.3.7.3. Service Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. Martinez Nieto.
    • 7.3.8.1. Company Overview
    • 7.3.8.2. Financial Performance
    • 7.3.8.3. Service Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. Menadiona
    • 7.3.9.1. Company Overview
    • 7.3.9.2. Financial Performance
    • 7.3.9.3. Service Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. NutraScience Labs
    • 7.3.10.1. Company Overview
    • 7.3.10.2. Financial Performance
    • 7.3.10.3. Service Benchmarking
    • 7.3.10.4. Strategic Initiatives
  • 7.3.11. Nutrivo LLC,
    • 7.3.11.1. Company Overview
    • 7.3.11.2. Financial Performance
    • 7.3.11.3. Service Benchmarking
    • 7.3.11.4. Strategic Initiatives
  • 7.3.12. Gemini Pharmaceuticals
    • 7.3.12.1. Company Overview
    • 7.3.12.2. Financial Performance
    • 7.3.12.3. Service Benchmarking
    • 7.3.12.4. Strategic Initiatives
  • 7.3.13. Biovencer Healthcare Pvt Ltd
    • 7.3.13.1. Company Overview
    • 7.3.13.2. Financial Performance
    • 7.3.13.3. Service Benchmarking
    • 7.3.13.4. Strategic Initiatives
  • 7.3.14. Rain Nutrience
    • 7.3.14.1. Company Overview
    • 7.3.14.2. Financial Performance
    • 7.3.14.3. Service Benchmarking
    • 7.3.14.4. Strategic Initiatives
  • 7.3.15. Vantage Nutrition (ACG group)
    • 7.3.15.1. Company Overview
    • 7.3.15.2. Financial Performance
    • 7.3.15.3. Service Benchmarking
    • 7.3.15.4. Strategic Initiatives
  • 7.3.16. LiquidCapsule
    • 7.3.16.1. Company Overview
    • 7.3.16.2. Financial Performance
    • 7.3.16.3. Service Benchmarking
    • 7.3.16.4. Strategic Initiatives
  • 7.3.17. DCC plc
    • 7.3.17.1. Company Overview
    • 7.3.17.2. Financial Performance
    • 7.3.17.3. Service Benchmarking
    • 7.3.17.4. Strategic Initiatives
  • 7.3.18. Nature's Value
    • 7.3.18.1. Company Overview
    • 7.3.18.2. Financial Performance
    • 7.3.18.3. Service Benchmarking
    • 7.3.18.4. Strategic Initiatives
  • 7.3.19. MPI NutriPharma BV
    • 7.3.19.1. Company Overview
    • 7.3.19.2. Financial Performance
    • 7.3.19.3. Service Benchmarking
    • 7.3.19.4. Strategic Initiatives
  • 7.3.20. FAVEA Czech Republic (Favea)
    • 7.3.20.1. Company Overview
    • 7.3.20.2. Financial Performance
    • 7.3.20.3. Service Benchmarking
    • 7.3.20.4. Strategic Initiatives
  • 7.3.21. MediGrun Naturprodukte GmbH (MediGrun)
    • 7.3.21.1. Company Overview
    • 7.3.21.2. Financial Performance
    • 7.3.21.3. Service Benchmarking
    • 7.3.21.4. Strategic Initiatives